Marc Levitt
Internal Medicine · Massapequa Park, NYNPI 1043217987
Payments from drug & device makers
Across 197 payments — averaging $30.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amgen$658
- GSK$576
- Sumitomo Pharma America, Inc.$562
- AbbVie$340
- Boehringer Ingelheim$298
- plus $3K from 33 others
What the payments were for
- Speaking & faculty fees$1382%
- Food & beverage$5,88798%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $1,014 |
| Amgen | 29 | $658 |
| GSK | 9 | $576 |
| Sumitomo Pharma America, Inc. | 9 | $562 |
| AbbVie | 18 | $340 |
| Boehringer Ingelheim | 14 | $298 |
| Regeneron Healthcare Solutions, Inc. | 6 | $288 |
| Esperion Therapeutics, Inc. | 4 | $188 |
| Abbott | 2 | $183 |
| Novo Nordisk | 9 | $153 |
| Corium, LLC | 3 | $151 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $150 |
| Exact Sciences | 7 | $149 |
| Phadia US Inc. | 2 | $147 |
| Novartis | 7 | $145 |
| Sanofi | 3 | $138 |
| Bayer | 4 | $104 |
| Johnson & Johnson | 4 | $89 |
| Lilly USA, LLC | 5 | $82 |
| Paratek Pharmaceuticals, Inc. | 4 | $81 |
| Amarin Pharma, Inc. | 3 | $62 |
| Pfizer | 3 | $47 |
| Merck | 2 | $43 |
| Renalytix AI, Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Eisai Inc. | 2 | $29 |
| Lundbeck LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Ardelyx, Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Radius Health, Inc. | 1 | $15 |
| Vistapharm, Inc. | 1 | $14 |
| Medicure Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,024 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 56 | $107,838 |
| JanuviaSitagliptin Phosphate | 16 | $25,126 |
| TrulicityDulaglutide | 15 | $24,985 |
| MounjaroTirzepatide | 20 | $24,608 |
| FarxigaDapagliflozin Propanediol | 18 | $18,855 |
| EliquisApixaban | 15 | $18,508 |
| JardianceEmpagliflozin | 12 | $18,455 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 99 | $3,181 |
| Fluticasone Propionate | 179 | $2,238 |
| FenofibrateFenofibrate Nanocrystallized | 67 | $2,135 |
| SynthroidLevothyroxine Sodium | 22 | $2,026 |
| Metoprolol Succinate | 109 | $1,810 |
| Levothyroxine Sodium | 102 | $1,133 |
| Atorvastatin Calcium | 169 | $1,075 |
| Ipratropium Bromide | 48 | $1,015 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $153 | $107,83856 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $82 | $49,59235 claims |
| MerckJanuvia | $43 | $25,12616 claims |
| AstraZenecaFarxiga | $1,014 | $18,85518 claims |
| PfizerEliquis | $47 | $18,50815 claims |
| Boehringer IngelheimJardiance | $298 | $18,45512 claims |
| AbbVieSynthroid | $340 | $2,02622 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Massapequa Park
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.